Results 161 to 170 of about 211,796 (270)

Validation of the Parental Self‐Efficacy in Managing Child Food‐Induced Anaphylaxis (PSEMA) Questionnaire for Ethnic Chinese Families With Food‐Allergic Children

open access: yes
Clinical &Experimental Allergy, EarlyView.
Christy Wing Man Leung   +5 more
wiley   +1 more source

Management of Non‐Plaque‐Induced Gingival Conditions: A Systematic Review—Part 2: Inflammatory and Immune Conditions; Neoplasms; and Gingival Pigmentation

open access: yesJournal of Clinical Periodontology, EarlyView.
ABSTRACT Aims This systematic review assesses current evidence on the management of non‐plaque (dental biofilm)‐induced gingival diseases and conditions (NPIGDs), including (i) inflammatory and immune conditions, (ii) neoplasms and (iii) gingival pigmentations.
Maria Clotilde Carra   +5 more
wiley   +1 more source

Non-allergenic immunotherapy

open access: yesAllergologia et Immunopathologia, 2017
Ibáñez Echevarría E   +2 more
openaire   +3 more sources

Faecal IgA but not salivary IgA is associated with canine atopic dermatitis

open access: yesJournal of Small Animal Practice, EarlyView.
Objectives To characterise immunoglobulin A (IgA) levels in the faeces and saliva of dogs with canine atopic dermatitis (CAD) and healthy breed matched controls. Materials and Methods Dogs with canine atopic dermatitis were recruited based on history, clinical examination and diagnostic testing where appropriate.
A. Campbell   +3 more
wiley   +1 more source

Allergen‐Sensitised Whole Blood Samples for Quality Control and Benchmarking of Basophil Activation Tests

open access: yes
Clinical &Experimental Allergy, EarlyView.
Léonard Bezinge   +8 more
wiley   +1 more source

Efficacy and Field Safety of the Second‐Generation, Highly Selective JAK1 Inhibitor Atinvicitinib for the Treatment of Canine Atopic Dermatitis: A Multicentre, Blinded, Randomised, Placebo‐Controlled Clinical Trial in Client‐Owned Dogs

open access: yesVeterinary Dermatology, EarlyView.
Background: Janus kinase (JAK) inhibitors alleviate pruritus and clinical signs of canine atopic dermatitis (cAD). Objective: To confirm the optimal dosing regimen of atinvicitinib, a second‐generation highly selective inhibitor of JAK1 in dogs. Conclusions and Clinical Relevance: Once‐daily atinvicitinib was safe, well‐tolerated and effective at ...
Faris Jirjis   +6 more
wiley   +1 more source

Yeast Surface Display for Efficient Generation of Nanobody‐Based Human IgG Targeting the 11S Globulin From Hazelnut, Cor a 9

open access: yes
Clinical &Experimental Allergy, EarlyView.
Bjarke Krogstrup Jensen   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy